000009449 000__ 01714cam\a22003855i\4500
000009449 001__ 9449
000009449 003__ SzGeWIPO
000009449 005__ 20240708161307.0
000009449 008__ 901008s1987\\\\onc\\\\\r\\\\u000\0\eng\d
000009449 035__ $$a(wipo)(CD )$6520
000009449 035__ $$a(OCoLC)1158975016
000009449 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000009449 043__ $$an-cn---
000009449 084__ $$a4$$qCA
000009449 1001_ $$aLourie, Alan D.,$$eauthor.
000009449 24510 $$aComment on Canada's pharmaceutical compulsory licensing provisions /$$cAlan D. Lourie.
000009449 264_1 $$aOttawa, Ontario :$$bIntellectual Property Institute of Canada,$$c1987.
000009449 300__ $$a1 volume ([5] pages) ;$$c[28] cm.
000009449 336__ $$atext$$btxt$$2rdacontent
000009449 337__ $$aunmediated$$bn$$2rdamedia
000009449 338__ $$avolume$$bnc$$2rdacarrier
000009449 4901_ $$aCanadian Intellectual Property Review = Revue Canadienne De Propriete Intellectuelle ;$$v1987 Vol 3 No 1 pages 21-26
000009449 650_0 $$aPatents$$zUnited States.
000009449 650_0 $$aIntellectual property$$zUnited States.
000009449 650_4 $$aPATENTS : PATENTABILITY : PHARMACEUTICAL PRODUCTS, MEDICINE, BIOLOGY
000009449 650_4 $$aPATENTS : PATENTABILITY
000009449 650_4 $$aPATENTS : TRANSFER AND TERMINATION OF RIGHTS : LICENSE, LICENSE AGREEMENTS : UNITED STATES OF AMERICA
000009449 651_0 $$aAmerica$$xCommerce$$xLaw and legislation.
000009449 651_0 $$aCanada$$xCommerce$$xLaw and legislation.
000009449 651_0 $$aUnited States$$xCommerce$$xLaw and legislation.
000009449 830_0 $$aCanadian Intellectual Property Review = Revue Canadienne De Propriete Intellectuelle ;$$v1987 Vol 3 No 1 pages 21-26.
000009449 903__ $$v1$$aCANADIAN INTELLECTUAL PROPERTY REVIEW = REVUE CANADIENNE DE PROPRIETE INTELLECTUELLE
000009449 904__ $$aJournal article
000009449 942__ $$cART$$2ddc
000009449 952__ $$w2006-11-03$$p1990-6520$$r0.00$$u9807$$bMAIN$$10$$kCA 4$$v1990-10-08$$zLibrary$$70
000009449 980__ $$aBIB
000009449 999__ $$c9726$$d9726